Search Results Search Sort by RelevanceMost Recent Policy Forum Mar 2007 Media Must Try Harder To Reach Groups at Risk for HIV/AIDS Rajiv Bhuta and William R. Leonard, PhD The media has a responsibility to do more to counter the stigma that has been placed on HIV and AIDS so that more at-risk patients will seek treatment. Virtual Mentor. 2007;9(1):210-214. doi: 10.1001/virtualmentor.2007.9.3.pfor2-0703. State of the Art and Science Jan 2007 Development of the Human Papillomavirus Vaccine and Guidelines for Its Use Amy L. Jonson, MD A physician explains the human papillomavirus vaccine and guidelines for its use. Virtual Mentor. 2007;9(1):30-33. doi: 10.1001/virtualmentor.2007.9.1.cprl1-0701. Medicine and Society Jun 2024 How to Mitigate Community Harms of Antibacterial Resistance With Patient-Centered Care Chelsea Modlin, MD Merits of more antimicrobial prescription oversight should be weighed against risks to patients and communities of untreatable bacterial infections. AMA J Ethics. 2024;26(6):E494-501. doi: 10.1001/amajethics.2024.494. Pagination First page « First Previous page ‹ Previous … Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Current page 20
Policy Forum Mar 2007 Media Must Try Harder To Reach Groups at Risk for HIV/AIDS Rajiv Bhuta and William R. Leonard, PhD The media has a responsibility to do more to counter the stigma that has been placed on HIV and AIDS so that more at-risk patients will seek treatment. Virtual Mentor. 2007;9(1):210-214. doi: 10.1001/virtualmentor.2007.9.3.pfor2-0703.
State of the Art and Science Jan 2007 Development of the Human Papillomavirus Vaccine and Guidelines for Its Use Amy L. Jonson, MD A physician explains the human papillomavirus vaccine and guidelines for its use. Virtual Mentor. 2007;9(1):30-33. doi: 10.1001/virtualmentor.2007.9.1.cprl1-0701.
Medicine and Society Jun 2024 How to Mitigate Community Harms of Antibacterial Resistance With Patient-Centered Care Chelsea Modlin, MD Merits of more antimicrobial prescription oversight should be weighed against risks to patients and communities of untreatable bacterial infections. AMA J Ethics. 2024;26(6):E494-501. doi: 10.1001/amajethics.2024.494.